factor, which affects the differentiation of T-lymphocytes in the thymus, their migration and function, is of interest [9] [10] [11] . We have shown the change in the colony-forming ability of the bone marrow-derived MMSCs during physiological variation of the thymulin level in the blood of CBA/Ca mice and after the application of thymic bioactive factors [12] . The involvement of different subpopulations of T-lymphocytes in the realization of MMSCs function such as differentiation in the osteogenic direction and control of hematopoiesis [13, 14] does not exclude the possibility of the influence of thymic hormones on these properties of MMSCs.
One of the promising approaches to the study of the interactions of the thymus and the bone marrow-derived MMSCs can be the carrying out of experiments in mice of different strains. In the literature, there is evidence of the importance of taking into account the animal genotype in assessing metabolic changes, functioning of the immune, endocrine system and MMSCs in bone marrow [15, 16] . The results of our previous studies showed that mice of different strains with models of thymus dysfunction differ in the ability to differentiate hematopoietic stem cells and proliferative potential of bone marrow-derived MMSCs [10, 17, 18] .
The purpose is to study the ability of murine bone marrow-derived MMSC to colony formation, directed differentiation and immunosuppressive effect at different content of serum thymic factor (thymulin) in the body and in the cell culture in mice of different strains.
Animals.
The studies were performed on 3-4 months old male FVB/N (genotype H-2q, n = 24) and 129/Sv (genotype H-2, n = 24) mice, keeping of the State Institute of Genetic and Regenerative Medicine NAMS Ukraine. The choice of these strains for research is explained by straindependent features of the functioning of the bone marrow, thymus and immune system [15, 17, 18] . Animals were at a 12:12 light:dark cycle and free access to water and food ad libitum. All works with experimental animals were carried out in compliance with the laws and principles of the «European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes» (Strasbourg, 1986) , as well as the Law of Ukraine «On the Protection of Animals from Cruelty» (of 21.02. 2006) .
Experimental groups of mice. The thymus dysfunction in mice was modelled by thymectomy under anesthesia (2.5 % avertin, 125 mg/kg, intraperitoneally). Control group -sham-operated animals of both strains. Blood and tissue were obtained after decapitation of mice under ether anesthesia in the morning (9.00 -10.00) 4 weeks after the operation.
Stages of the experiment. In experimental mice, the endocrine function of the thymus was assessed in vivo. In experiments in vitro, the clonogenic potential of bone marrow-derived cells was studied, the MMSCs phenotyping, the estimation of the osteogenic and adipogenic potential of MMSCs, the immunomodulating properties of MMSCs, and the possibility of the direct effect of thymulin on the biological properties of MMSCs of thymectomized animals were performed.
Endocrine function of the thymus was assessed by the level of thymulin in the blood [19] . The method is based on the ability of thymulin to restore azathioprine sensitivity of spontaneous rosette-forming spleen cells of adult thymectomized mice. For centrifugal ultrafiltration of animal serum we used Centriflo CF-50A (Amicon, USA) conical filters to eliminate the high-molecular-weight inhibitor of thymulin. The thymulin titer was the last serum dilution, which caused a 50 % reduction in the number of rosette-forming spleen cells relative to the control. The results were expressed as log 2 of the hormone titer. In thymectomized mice, the serum level of thymulin should be zero.
Bone marrow cells were obtained by flushing of the femurs by RPMI-1640 medium (Sigma, USA). Cultivation was carried out in 25 cm 2 culture flasks in the RPMI-1640 medium, supplemented with 10 % fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin (all -Sigma, USA).
Phenotyping of the bone marrow-derived MMSCs was carried out using monoclonal antibodies against markers Sca-1, CD44, CD73, CD90, CD45 (Becton Dickinson, USA). Cell samples without antibodies (unstaining control) were used as negative control. The fluorescence was also analyzed in samples with each of the antibodies separately (single staining controls). The analysis was performed with cell sorter BD FACSAria (Becton Dickinson, USA).
The study of clonogenic potential of bone marrow cells. The bone marrow cells in monolayer cultures in vitro forms colonies, consisting of colony-forming units of fibroblasts (CFU-F) [20] . Bone marrow cells with a seed density of 2•10 5 cells/cm 2 were cultured in a complete medium containing 85 % RPMI-1640, 15 % FBS, 2 mM L-glutamine, (Sigma, USA) for 12 days at 37 °C in a humidified atmosphere containing 5 % CO 2 . Under a binocular microscope, the number of colonies, which consisted of not less than 50 cells, was counted. The result was expressed in the number of colonies per 1•10 6 bone marrow cells. To assess the osteogenic potential of MMSCs, the bone marrow cells of the 3rd passage were cultured in an osteoinductive medium consisting of DMEM with 1.0 g/L glucose, 10 % fetal calf serum (FCS), 100 nM dexamethasone, 10 mM β-glycerophosphate, 0.05 mM L-ascorbate-2-phosphate (all -Sigma, USA) [21] . After 21 days, the monolayer of cells was washed with phosphate buffered saline (PBS), fixed with 10 % paraformaldehyde solution, and then stained with 2 % Alizarin Red S (Sigma, USA). Semiquantitative analysis of the mineralization degree of stained cultures was carried out by the colorimetric method according to C. Gregory [22] . The dye bound to the calcified extracellular matrix was extracted with acetic acid and pH was adjusted to 4.1 with ammonium hydroxide. The degree of staining was evaluated on Multiskan EX (Thermo Scientific, USA) microplate photometer at a wavelength of 405 nm.
To assess the adipogenic potential of MMSCs, bone marrow cells of the 3rd passage were cultured in an adipogenic differentiation medium consisting of DMEM with 4.5 g/L glucose, 5 % horse serum, 10 % FCS, 1 μM dexamethasone, 200 μM indomethacin, 500 μM isobutylmethylxanthine and 5 μg/mL insulin (all -Sigma, USA). After 14 days, the cultures were washed with PBS, fixed using 10 % paraformaldehyde solution, and then stained with Oil Red O (Sigma, USA) to detect lipid inclusions [23] . Under the inverted microscope IX71 (Olympus, Japan), cells that contained and did not contain lipid droplets in 10 random fields of view were counted. The results were expressed as a percentage.
Immunomodulating effect of bone marrow MMSCs of the 3 rd passage on mitogen-stimulated proliferation of syngeneic murine splenocytes was studied in the phytohemagglutinin-induced lymphocyte blast transformation test using the MTT assay [24] . Splenocytes were incubated with 0.01 mg/mL phytohemagglutinin without and with the addition of MMSCs at different doses of 1. For estimation of thymulin effects in vitro, bone marrow-derived MMSCs of thymectomized mice were incubated with thymulin (Sigma, USA) at concentrations of 1 ng/mL and 10 ng/mL and analyzed their clonogenic potential. When studying the influence of the thymulin on directed differentiation, it was added at a concentration of 1 ng/mL at each change of differentiation medium. When studying the immunomodulatory properties of MMSCs, thymulin was added at a concentration of 1 ng/mL at each change of the nutrient medium. In all experiments, the values were Statistical analysis was carried out using the Statistica 7 software (StatSoft Inc., USA). The differences between the groups was assessed using Student's t-test. The results are presented as means and standard error of mean (M ± m). The difference between the groups was considered statistically significant at a value of p < 0.05 [25] .
MATERIALS AND METHODS

EFFECT OF THYMECTOMY ON THE LEVEL OF THYMULIN IN FVB/N AND 129/SV MICE.
We established that the level of thymulin in control sham-operated FVB/N mice is higher than in 129/Sv mice and is 5.3 ± 0.3 and 4.3 ± 0.2 log 2 titer (p < 0.05), respectively. In thymectomized mice of the studied strains, the hormone was not detected in the blood. Fig. 1) . In thymectomized mice of both strains, the CFU-F number are less (p < 0.05) than in control groups (Fig. 1) . The difference between the studied groups is more expressed in FVB/N mice (1.9 times) than in 129/Sv (1.4 times).
THE EFFECT OF THYMECTOMY ON THE BIOLOGICAL PROPERTIES OF THE BONE MARROW-DERIVED MMSCS OF FVB
Therefore, the ability of bone marrow progenitor cells to colony formation in control sham-operated and thymectomized mice depends on their genotype. After the addition of thymulin at a concentration of 10 ng/mL in cell culture of thymectomized mice of both strains, the amount of CFU-F increases in comparison with bone marrow cells of thymectomized and thymectomized with the addition of thymulin at a concentration of 1 ng/mL (Fig.1) .
The ability of the bone marrow MMSCs to directed differentiation. In parallel with the study of bone marrow MMSCs ability to the directed differentiation, a characterization of the MMSCs phenotype was performed. Cultured bone marrow MMSCs of the 3rd passage of both mice strains express typical CD44, CD73, CD90, and Sca-1 markers and do not express the pan-leukocyte marker CD45 (Table 1) .
It has been established that the osteogenic potential of bone marrowderived MMSCs in the control sham-operated FVB/N mice is higher than in 129/Sv mice, while the adipogenic one is lower (Fig. 2, 3) . After thymectomy, MMSCs differentiation in the osteogenic direction is observed in FVB/N mice, and in 129/Sv mice, there is its decrease (Fig. 2) .
The ability of MMSCs to adipogenic differentiation decreases in thymectomized FVB/N mice and does not change in 129/Sv mice (Fig. 3) . Thus, in mice, both intact and thymectomized, strain-dependent differences in the directed differentiation of bone marrow-derived MMSCs were revealed.
When evaluating the effect of thymulin in vitro on the osteogenic potential of bone marrow-derived MMSCs of thymectomized mice, its significant increase in 129/Sv mice and absence of changes in the FVB/N mice are shown (Fig. 2) . The adipogenic differentiation rate, after incubation of MMSCs with thymulin, did not change in 129/Sv mice and was increased in FVB/N mice.
Immunomodulating effect of bone marrow-derived MMSCs on mitogen-stimulated proliferation of splenocytes. Bone marrow-derived MMSCs of all the experimental groups show an immunosuppressive effect on the mitogen-activated proliferative response of splenocytes in MMT assay (Fig. 4, 5) . Thus, bone marrow MMSCs of the control sham-operated FVB/N mice at doses of 1. (Fig. 5) . At the same time, the lymphocyte blast transformation index in 129/Sv mice significantly exceeds those in FVB/N mice (Fig. 4, 5) .
It was established that the proliferative potential of splenocytes in the lymphocyte blast transformation test did not change after co-culture with MMSCs of both mice strains, previously incubated with thymulin (p > 0.05).
Therefore, we have established the immunosuppressive effect of bone marrow-derived MMSCs in mice of both strains. In this case, strain-dependent differences in this effect are manifested in the degree of immunosuppression and after thymectomy, in the type of its changes. Thymulin in vitro is able to change the clonogenic and osteogenic potential of bone marrow-derived MMSCs of thymectomized mice of both strains, while the adipogenic potential was recovered in FVB/N mice, the immunosuppressive effect of MMSCs remained unchanged.
Thus, the results of our in vivo and in vitro studies have made it possible to establish a definite relationship between changes in the biological 
RESULTS AND DISCUSSION
Notes: * -p < 0.05 compared with sham-operated mice; # -p < 0.05 compared with thymectomized mice; & -p < 0.05 compared with FVB/N mice. B-G -the micrographs of the directly differentiated in the osteogenic medium bone marrow-derived MMSCs of FVB/N (B-D) and 129/Sv (E-G) mice: B, E -sham-operated mice; C, F -thymectomized mice; D, G -thymectomized mice + thymulin at 1ng/mL in vitro; Alizarin Red S staining, phase contrast.
properties of bone marrow-derived MMSCs and the endocrine function of the thymus, which exhibits strain-dependent features. It was shown that in the control sham-operated FVB/N mice, the colony-forming ability of bone marrow cells significantly exceeds that of 129/Sv mice and at the same time is associated with a higher level of thymulin in blood. Recovery of thymectomized mice with a reduced ability of the bone marrow population to colony formation after incubation with thymulin may be associated with an increase in expression of growth factor cells under the influence of this hormone. Land et al. [26] have shown that in the culture of fetal lung tissue, thymulin at a dose of 1.0 ng/mL increases the expression of fibroblasts growth factors FGF9 and FGF10, which is associated with massive proliferation of undifferentiated mesenchymal tissue.
One of the main properties of MMSCs is their ability to differentiate into different cell types of connective tissue [27, 28] . In our work, we evaluated the ability of bone marrow-derived MMSCs of FVB/N and 129/ Sv mice to differentiate in the osteogenic and adipogenic directions. It was shown that the balance between these differentiation directions is controlled by cellular factors and can change in conditions of dysfunction of the immune system [13, 29] . Thus, in mice with age-related T-cell deficiency, the number of cells expressing osteoblast specific transcription factors Runx2 and Dlx5, osteoblast markers, collagen and osteocalcin decreases in the bone marrow and, conversely, the number of cells expressing the adipospecific transcription factor PPARγ2 increases, which stimulates differentiation of adipocytes and development of autocrine and paracrine factors inhibiting osteogenesis [29] .
In our experiment, in sham-operated FVB/N mice with a higher level of thymulin in the blood, the differentiation of MMSCs was predominantly in an osteogenic direction, in contrast to 129/Sv mice, in which we observed a differentiation shift towards adipogenesis. According to Oksimets et al. [30] , cytokines IL-1β, IL-2, IL-6, IL-8, TNF-α, which are secreted by transplanted MMSCs, play an important role in regulation of osteogenesis in injured limbs. The involvement of transcription factor NF-κB in implementation of thymulin effect in tissues in vivo and in vitro has been shown by altering the synthesis of proinflammatory (TNF-α, IL-1β, IL-6) and anti-inflammatory cytokines (IL-10) [31] .
It is also possible that differences in MMSCs differentiation potential of the studied control mice can be related to strain-dependent features of the functional state of the neuroendocrine system. For example, in FVB/N mice, the level of thyroxine (T4) in the blood is almost three times higher than that of 129/Sv mice, while in rats deficient in T4, the differentiation of MMSCs in the osteogenic direction is strongly inhibited [32, 33, 34] . It has been shown that melatonin stimulates differentiation of osteoblast precursors, increases osteoblast activity and expression of collagen type 1, osteopontin and osteocalcin [11, 35, 36] . According to our data, the level of melatonin in the blood of FVB/N mice [18] exceeds that of 129/Sv mice (unpublished data).
C F D G E B А
The results of the experiments with the incubation of MMSCs of thymectomized 129/Sv mice with thymulin allowed to obtain a new understanding of possible ways of hormone effects on the reduced osteogenic potential of bone marrow-derived MMSCs. In our earlier studies, we showed that osteogenesis, reduced at thymic hormones (in particular, thymulin) deficiency, can be restored by injections of thymic bioactive factors [37] .
At the same time, a sufficiently high degree of mineralization of the extracellular matrix of FVB/N mice MMSCs cultures is further enhanced after removal of the thymus and does not change after incubation with thymulin in vitro. It is known that the regulatory effect of thymus hormones on target cells depends on their initial state [38] . Therefore, we do not exclude the fact that the results obtained most likely reflect the straindependent features of MMSCs reaction to changes in the level of thymulin in the blood and in the cell culture media. Earlier we have already shown the difference in the response of bone marrow-derived MMSCs of FVB/N mice from other strains to the change in the level of thymulin in the blood under stress conditions [17] . According to Nikolskiy et al. [39] , dysbalance and dysfunction of stromal cells (in particular, activation of lineage differentiation of MMSCs in the osteogenic direction) can be mediated by quantitative and functional disorders in the subpopulations of immune cells (thymocytes).
Under physiological conditions, T-lymphocytes play a protective role in the metabolism of bone tissue, and osteogenesis decreases in animals ORIGINAL RESEARCH with a deficit of СD4 + and СD8 + T cells in bone marrow [13] . At the same time, dysbalance of СD4 + /СD8 + cells is observed in the bone marrow of thymectomized FVB/N mice, characterized by a significant decrease in the number of СD8 + cells and an increase in the number of СD4 + cells [10] . The shift toward enrichment of the bone marrow of such СD4 + mice is combined with cells with an increase in the differentiation of MMSCs in the osteogenic direction. It is shown that СD4 + T cells produce IL-17, which is a powerful growth factor for MMSCs [13] . Simultaneous inhibition of adipogenic differentiation in thymectomized FVB/N mice gives us grounds for supposing that their MMSCs predominantly differentiates in the osteogenic direction, which explains the increased mineralization of the extracellular matrix of cell cultures.
The obtained results can indicate the prospects of using FVB/N and 129/Sv mice, including thymectomized, to study the influence of factors with both suppressive and activating effects on the bone marrow osteogenic differentiation of MMSCs. In addition, the mice of these strains can be useful in studying the influence of different subpopulations of T-lymphocytes on the function of the bone marrow-derived MMSCs.
We also found that in the mice of both strains the bone marrow-derived MMSCs have an immunosuppressive effect on mitogen-activated T-lymphocytes. At the same time, the intensity of the MMSCs effect depends on the mice strain and is not related to the specific features of the proliferative potential of T-lymphocytes. From the literature it is known [40] [41] [42] . One way of immunosuppressive action of MMSCs on T-cells can be the secretion of a number of cytokines -TGFβ (transforming growth factor β), HGF (hepatocyte growth factor), PGE2 (prostaglandin E2) [43] .
In our experiment, the more pronounced immunosuppressive effect of MMSCs of the control FVB/N mice may be associated with a higher intensity of production by the cells of these mice cytokines/mediators that suppress T-lymphocytes [18] . Strain-dependent features of changes in not only the intensity but also the spectrum of the cytokines produced by these cells can apparently explain the change in the immunosuppressive effect of MMSCs after thymectomy (from its increase in FVB/N mice to a decrease in 129/Sv mice). Strain-dependent differences in the interaction of MMSCs and some hormones, in particular, the response of these cells to the effect of glucocorticoids, may also be important [44] . Earlier we showed an increase in the level of glucocorticoids in the blood of thymectomized mice, as well as the lack of their suppressor effect on cells and mediators of the immune system in FVB/N mice, in contrast to mice of other strains [17] .
Thus, we have obtained data that prove the important role of the thymus in the manifestation of the biological properties of the bone marrow-derived MMSCs. In this case, the effect of thymus and its hormone thymulin on these cells depends on the genotype of the mice. The results obtained can be useful in the development of individualized cell therapy of damage of various genesis, in particular the musculoskeletal system, in conditions of dysfunction of central immune system. 
CONCLUSION
